Deflazacort

Journal of Postgraduate Medicine

Volumn 55, Issue 4, 2009, Pages 296-300

  Joshi, N ^a   Rajeshwari, K ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Children; Deflazacort; Efficacy; Safety; Usage

Indexed keywords

CALCIUM; DEFLAZACORT; PLACEBO; PREDNISOLONE; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADRENAL SUPPRESSION; ASTHMA; BENIGN CHILDHOOD EPILEPSY; CANDIDIASIS; CARDITIS; CATARACT; CLINICAL TRIAL; CUSHINGOID SYNDROME; DERMATOMYOSITIS; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG ELIMINATION; DUCHENNE MUSCULAR DYSTROPHY; DYSPEPSIA; GROWTH RETARDATION; HIRSUTISM; HUMAN; HYPERTENSION; HYPOKALEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMPAIRED GLUCOSE TOLERANCE; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOMA; MUSCLE WEAKNESS; NEPHROTIC SYNDROME; OBESITY; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PEPTIC ULCER; PSYCHOSIS; REVIEW; RHEUMATIC CARDITIS; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SIDE EFFECT; STRESS FRACTURE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION; TREATMENT WITHDRAWAL; WEIGHT GAIN; WOUND HEALING;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; ASTHMA; CHILD; GLUCOCORTICOIDS; GLUCOSE; GROWTH DISORDERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LEUKOCYTES, MONONUCLEAR; MALE; OSTEOPOROSIS; PREDNISOLONE; PREGNENEDIONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77249152253     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.58942     Document Type: Review

References (35)

1. Markham A, Bryson HM. Deflazacort: A review of its pharmacological properties and therapeutic efficacy. Drugs 1995;50:317-333
2. Avioli LV. Potency ratio: A brief synopsis. Br J Rheumatol 1993;32:24-26
3. Saviola G, Abdi Ali L, Shams Eddin S, Coppini A, Cavalieri F, Campostrini L, et al. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl-prednisolone in male inflammatory arthropathies: A 12 month open randomized pilot study. Rheumatology 2007;46:994-998
4. Belker ME, Massey DM, Vaughan L. Comparative clinical efficacy of deflazacort and prednisone in the treatment of steroid-dependent asthma and asthmatic bronchitis (a multicenter study). Kansas City, (KS): Clinical Research and Statistics Department, Marion Merrel Dow; 1993.
5. Krogsgaard MR, Lund B, Johnsson B. A long term prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica. J Rheumatol 1995;22:1660-1662
6. Anderson JE, McIntosh LM, Poettcker R. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse. Muscle Nerve 1996;19:1576-1585
7. Mesa LE, Dubrovsky AL, Corderi J, Marco P, Flores D. Steroids in Duchenne muscular dystrophy-deflazacort trial. Neuromuscul Disord 1991;1:261-266
8. Angelini C, Pegoraro E, Turella E, Intino MT, Pini A, Costa C. Deflazacort in Duchenne dystrophy: Study of long-term effect. Muscle Nerve 1994;17:386-391
9. Biggar WD, Gingras M, Fehlings DL, Harris VA, Steele CA. Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr 2001;138:45-50.
10. Silversides CK, Webb GD, Harris VA, Biggar DW. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 2003;91:769-772
11. Alman BA, Raza SN, Biggar WD. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy. J Bone Joint Surg Am 2004;86:519-524
12. Biggar WD, Politano L, Harris VA, Passamano L, Vajsar J, Alman B, et al. Deflazacort in Duchenne muscular dystrophy: A comparison of two different protocols. Neuromuscul Disord 2004;14:476-482
13. Reitter B. Deflazacort vs prednisone in Duchenne muscular dystrophy: Trends of an ongoing study. Brain Dev 1995;17:39-43.
14. Brooke MH. A randomized trial of deflazacort and prednisone in Duchenne muscular dystrophy: Efficacy and toxicity. Neurology 1996;46:476-478
15. Bonifati MD, Ruzza G, Bonometto P, Berardinelli A, Gorni K, Orcesi S, et al. A multicentre, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 2000;23:1344-1347 (Pubitemid 30690987)
16. Campbell C, Jacob P. Deflazacort for the treatment of Duchenne Dystrophy: A systematic review. BMC Neurol 2003;3:7.
17. Penaloza J, Sojo ET, Caletti MG, Mendilaharzu F. Evaluation of Deflazacort: A new steroid, in the initial therapy of children with idiopathic nephrotic syndrome. Med Infant 1994;1:185-189 (Spanish). Available from: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/?IsisScript 5 iah/iah.xisandsrc 5 googleandbase 5 LILACSandlang 5 pandnext Action 5 lnkandexprSearch 5 281711andindexSearch 5 ID#bottom.
18. Lee CY, Chung HK, Park JS. The effect of Calcort (Deflazacort) in connective tissue diseases and nephrotic syndrome in child hood. Korean Med Database 1995;38:88-93. Available from: Http://kmbase.medric.or.kr/Main.aspx? d 5 KMBASE andm 5 VIEWandi 5 0378019950380010088.
19. Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol 1997;11:418-422
20. Loftus J, Allen R, Hesp R, David J, Reid DM, Wright DJ, et al. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: A relatively bone-sparing effect of deflazacort. Pediatrics 1991;88:428-436
21. Mullol J, Xaubet A, López E, Roca-Ferrer J, Picado C. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995;50:270-274
22. Gartner S, Cobos N, Pérez-Yarza EG, Moreno A, De Frutos C, Liñan S, et al. Comparative efficacy of oral deflazacort versus oral prednisolone in children with moderate acute asthma. Ann Pediatr 2004;61:207-212
23. Schärer K, Feneberg R, Klaus G, Paschen C, Wüster C, Mehls O, et al. Experience with deflazacort in children and adolescents after renal transplantation. Pediatr Nephrol 2000;14:457-463
24. Ferraris JR, Pasqualini T. Therapy with a new glucocorticoid: Effect of deflazacort on linear growth and growth hormone secretion in renal transplantation. J Rheumatol 1993;37:43-46
25. Kim YS, Kim MS, Kim SI, Lim SK, Lee HY, Han DS, et al. Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: A prospective trial in renal transplants. Transpl Int 1997;10:197-201.
26. Ferraris J, Krmar R, Flores D, Giogieri S, Díaz L, Tessler J. Pharmacokinetics of deflazacort in renal transplanted and hemodialyzed children. Clin Nephrol 1998;50:172-177
27. Gobbi M, Scudeletti M. Deflazacort in the treatment of haematologic disorders. Eur J Clin Pharmacol 1993;45:S25-28.
28. Mazzucconi MG, Malagnino F, De Laurentis C, Criscuolo D. Deflazacort in thrombocytopenia: A comparison with prednisone. Int J Clin Pharmacol Ther Toxicol 1980;18:538-542
29. Grosso S, Farnetani M, Mostardini R, Cordelli D, Berardi R, Balestri P. A comparative study of hydrocortisone versus deflazacort in drug-resistant epilepsy of childhood. Epilepsy Res 2008;81:80-85
30. LoCascio V, Ballanti P, Milani S, Bertoldo F, LoCascio C, Zanolin EM, et al. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus deflazacort. Calcif Tissue Int 1998;62:199-204.
31. Humphrey EL, Williams JH, Davie MW, Marshall MJ. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 2006;38:652-661
32. Balsan S, Stéru D, Bourdeau A, Grimberg R, Lenoir G. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth. Calcif Tissue Int 1987;40:303-309
33. Ferraris JR, Pasqualini T, Alonso G, Legal S, Sorroche P, Galich AM, et al. Effects of deflazacort vs methylprednisone: A randomized study in kidney transplant patients. Pediatr Nephrol 2007;22:734-741
34. Babadjanova G, Allolio B, Vollmer M, Reincke M, Schulte HM.Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects. Eur J Clin Pharmacol 1996;51:53-57
35. Wajchenberg BL, Cesar FP, Luthold WW, Okada H, Borghi VC. Comparison of the subacute effects of a new glucocorticoid, deflazacort, and prednisone on the hypothalamic-pituitary-adrenal axis of normal subjects. Braz J Med Biol Res 1986;19:39-47.